Why Is Bausch (BHC) Down 13% Since Last Earnings Report?
Bausch (BHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
| Ticker |
BHC
|
| CIK | 0000885590 |
| SIC | 2834 |
| Sector | Manufacturing |
| Industry Category | Pharmaceutical Products |
| Industry Group | Pharmaceutical Preparations |
| Address | 2150 ST. ELZEAR BLVD. WEST, LAVAL, QUEBEC, A8, H7L 4A8 |
| Website | bauschhealth.com |
| Phone | 514-744-6792 |
| CEO | Thomas J. Appio |
| Employees | 19,900 |
Our team will help you customize a package that meets the needs of your business.
Request a Consultation|
Standardized FinancialsdocsIntrinio provides professional-grade historical financial data. This data is standardized, cleansed and verified to ensure the highest quality data sourced directly from the XBRL financial statements. The primary purpose of standardized financials are to facilitate comparability across a single company’s fundamentals and across all companies fundamentals. For example, it is possible to compare total revenues between two companies as of a certain point in time, or within a single company across multiple time periods. This is not possible using the as reported financial statements because of the inherent complexity of reporting standards. Below is a preview of several data points from each financial statement, as well as a sample of our many calculated metrics: |
|||||||||||||||||||||
|
Income Statement
|
Balance Sheet
|
||||||||||||||||||||
|
Cash Flow Statement
|
Calculations
|
||||||||||||||||||||
|
Latest NewsdocsIntrinio provides up-to-date news articles on every US company from various sources. Here are several examples: |
Why Is Bausch (BHC) Down 13% Since Last Earnings Report?Bausch (BHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. With 51% institutional ownership, Bausch Health Companies Inc. (NYSE:BHC) is a favorite amongst the big gunsKey Insights Given the large stake in the stock by institutions, Bausch Health Companies' stock price might be... Bausch + Lomb, Organon, Globalstar, Telephone and Data Systems, and nLIGHT Shares Skyrocket, What You Need To KnowA number of stocks jumped in the afternoon session after the major indices rebounded (Nasdaq +2.0%, S&P 500 +1.5%) as President Trump postponed the planned 50% tariff on European Union imports, shifting the start date to July 9, 2025. 3 Reasons to Avoid BLCO and 1 Stock to Buy InsteadShareholders of Bausch + Lomb would probably like to forget the past six months even happened. The stock dropped 42.8% and now trades at $11.19. This was partly driven by its softer quarterly results and might have investors contemplating their next move. Bausch Health Announces 2025 Annual Meeting of Shareholder ResultsLAVAL, QC / ACCESS Newswire / May 14, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) today announced the election of the 10 directors nominated at its 2025 annual meeting of shareholders ("Annual Meeting") held on May 13, 2025. The detailed ... |